Shopping Basket
Your shopping basket is empty.
Teva/Ratiopharm gets EU clearance
The European Commission today approved Teva Pharmaceuticals Industries’ acquisition of Merckle Group’s Ratiopharm pharmaceutical business, subject to divestitures.
Purchase an approved for publication custom PDF below.
An official PDF provides excellent marketing opportunities, enabling you to post the article online, make reprints and distribute under the GCR brand.
- £100 (GBP)
Related Products
Featured Products
GCR April/May 2012
- $200 (GBP)
- More info / Buy
Rating Enforcement 2011
- $300 (GBP)
- More Info / Buy
GCR 100 - 11th Edition
- $200 (GBP)
- More Info / Buy
